Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Tax Provisions (2024 - 2025)

Historic Tax Provisions for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $34794.0.

  • Neuphoria Therapeutics' Tax Provisions rose 39971.57% to $34794.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$347787.0, marking a year-over-year change of. This contributed to the annual value of -$468366.0 for FY2025, which is 43637.88% down from last year.
  • Latest data reveals that Neuphoria Therapeutics reported Tax Provisions of $34794.0 as of Q4 2025, which was up 39971.57% from -$34793.0 recorded in Q3 2025.
  • Neuphoria Therapeutics' Tax Provisions' 5-year high stood at $34794.0 during Q4 2025, with a 5-year trough of -$266602.0 in Q2 2025.